Cargando…
Costocondritis y espondilitis diferidas por Candida en paciente post-COVID-19 tratado previamente con corticoides, antibióticos y tocilizumab
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SEPAR. Published by Elsevier España, S.L.U.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832559/ https://www.ncbi.nlm.nih.gov/pubmed/34629649 http://dx.doi.org/10.1016/j.arbres.2020.12.002 |
| _version_ | 1783641863601782784 |
|---|---|
| author | Gorospe-Sarasúa, Luis Gallego-Rivera, José Ignacio Muñoz-Molina, Gemma María Mirambeaux-Villalona, Rosa Mariela Ajuria-Illarramendi, Odile González-García, Andrés Barbolla-Díaz, Ignacio |
| author_facet | Gorospe-Sarasúa, Luis Gallego-Rivera, José Ignacio Muñoz-Molina, Gemma María Mirambeaux-Villalona, Rosa Mariela Ajuria-Illarramendi, Odile González-García, Andrés Barbolla-Díaz, Ignacio |
| author_sort | Gorospe-Sarasúa, Luis |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7832559 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | SEPAR. Published by Elsevier España, S.L.U. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78325592021-01-26 Costocondritis y espondilitis diferidas por Candida en paciente post-COVID-19 tratado previamente con corticoides, antibióticos y tocilizumab Gorospe-Sarasúa, Luis Gallego-Rivera, José Ignacio Muñoz-Molina, Gemma María Mirambeaux-Villalona, Rosa Mariela Ajuria-Illarramendi, Odile González-García, Andrés Barbolla-Díaz, Ignacio Arch Bronconeumol Carta Científica SEPAR. Published by Elsevier España, S.L.U. 2021-04 2020-12-28 /pmc/articles/PMC7832559/ /pubmed/34629649 http://dx.doi.org/10.1016/j.arbres.2020.12.002 Text en © 2020 SEPAR. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Carta Científica Gorospe-Sarasúa, Luis Gallego-Rivera, José Ignacio Muñoz-Molina, Gemma María Mirambeaux-Villalona, Rosa Mariela Ajuria-Illarramendi, Odile González-García, Andrés Barbolla-Díaz, Ignacio Costocondritis y espondilitis diferidas por Candida en paciente post-COVID-19 tratado previamente con corticoides, antibióticos y tocilizumab |
| title | Costocondritis y espondilitis diferidas por Candida en paciente post-COVID-19 tratado previamente con corticoides, antibióticos y tocilizumab |
| title_full | Costocondritis y espondilitis diferidas por Candida en paciente post-COVID-19 tratado previamente con corticoides, antibióticos y tocilizumab |
| title_fullStr | Costocondritis y espondilitis diferidas por Candida en paciente post-COVID-19 tratado previamente con corticoides, antibióticos y tocilizumab |
| title_full_unstemmed | Costocondritis y espondilitis diferidas por Candida en paciente post-COVID-19 tratado previamente con corticoides, antibióticos y tocilizumab |
| title_short | Costocondritis y espondilitis diferidas por Candida en paciente post-COVID-19 tratado previamente con corticoides, antibióticos y tocilizumab |
| title_sort | costocondritis y espondilitis diferidas por candida en paciente post-covid-19 tratado previamente con corticoides, antibióticos y tocilizumab |
| topic | Carta Científica |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832559/ https://www.ncbi.nlm.nih.gov/pubmed/34629649 http://dx.doi.org/10.1016/j.arbres.2020.12.002 |
| work_keys_str_mv | AT gorospesarasualuis costocondritisyespondilitisdiferidasporcandidaenpacientepostcovid19tratadopreviamenteconcorticoidesantibioticosytocilizumab AT gallegoriverajoseignacio costocondritisyespondilitisdiferidasporcandidaenpacientepostcovid19tratadopreviamenteconcorticoidesantibioticosytocilizumab AT munozmolinagemmamaria costocondritisyespondilitisdiferidasporcandidaenpacientepostcovid19tratadopreviamenteconcorticoidesantibioticosytocilizumab AT mirambeauxvillalonarosamariela costocondritisyespondilitisdiferidasporcandidaenpacientepostcovid19tratadopreviamenteconcorticoidesantibioticosytocilizumab AT ajuriaillarramendiodile costocondritisyespondilitisdiferidasporcandidaenpacientepostcovid19tratadopreviamenteconcorticoidesantibioticosytocilizumab AT gonzalezgarciaandres costocondritisyespondilitisdiferidasporcandidaenpacientepostcovid19tratadopreviamenteconcorticoidesantibioticosytocilizumab AT barbolladiazignacio costocondritisyespondilitisdiferidasporcandidaenpacientepostcovid19tratadopreviamenteconcorticoidesantibioticosytocilizumab |